Huang, J. and Zhang, Z. and Jian, J. and Li, M. and Tian, T. and Zhang, S. and Yang, K. and Ji, R. and Liu, F. and Zhao, Z. and Tang, Y. and Shi, W. and Li, J.
doi:10.1016/j.jaad.2026.07.089
Abstract
Routine laboratory monitoring is recommended during JAK inhibitor therapy, but its clinical yield in patients with alopecia areata has not been prospectively characterized.